Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 6, 2011, Pages 370-376

  Bala, M ^a   Kopp, A ^a   Wurm, S ^a   Buchler C ^a   Scholmerich J ^a   Schaffler A ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

chemokine; cytokine; diabetes; lipoprotein; LPS; monocyte

Indexed keywords

CHEMOKINE; HEMOGLOBIN A1C; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; RESISTIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES CONTROL; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SUPERNATANT;

ADULT; AGED; AGED, 80 AND OVER; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHEMOKINES; COHORT STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MALE; MIDDLE AGED; MONOCYTES;

EID: 79958248856     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1268413     Document Type: Article

References (31)

1. Weisberg SP, Hunter D, Huber R et al,. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006 116 115-124 (Pubitemid 43121796)
2. Lehrke M, Lazar MA. Inflamed about obesity. Nat Med 2004 10 126-127 (Pubitemid 38524875)
3. Xu H, Barnes GT, Yang Q et al,. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003 112 1821-1830 (Pubitemid 38063705)
4. Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest 2006 116 33-35 (Pubitemid 43121788)
5. Schaffler A, Muller-Ladner U, Scholmerich J et al,. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 2006 27 449-467 (Pubitemid 44213227)
6. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003 112 1785-1788 (Pubitemid 38063699)
7. Dahlman I, Kaaman M, Olsson T et al,. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005 90 5834-5840 (Pubitemid 41415500)
8. Kanda H, Tateya S, Tamori Y et al,. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006 116 1494-1505
9. Pataky Z, Bobbioni-Harsch E, Golay A. Obesity: a complex growing challenge. Exp Clin Endocrinol Diabetes 2010 118 427-433
10. Schlienger JL, Pradignac A, Vinzio S et al,. Hyperglycemia in the critically ill: meaning and treatment. Presse Med 2009 38 562-570
11. Muller B. Endocrine aspects of critical illness. Ann Endocrinol (Paris) 2007 68 290-298
12. Hickman MS, Schwesinger WH, Page CP. Acute cholecystitis in the diabetic. A case-control study of outcome. Arch Surg 1988 123 409-411
13. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005 115 911-919 quiz 920
14. Lue H, Kleemann R, Calandra T et al,. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002 4 449-460 (Pubitemid 34270682)
15. Kleemann R, Bucala R. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediators Inflamm 2010 610479
16. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004 255 439-447 (Pubitemid 38446357)
17. Kopp A, Gross P, Falk W et al,. Fatty acids as metabolic mediators in innate immunity. Eur J Clin Invest 2009 39 924-933
18. Qatanani M, Szwergold NR, Greaves DR et al,. Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest 2009
19. Stogbauer F, Neumeier M, Weigert J et al,. Highly efficient and low-cost method to isolate human blood monocytes with high purity. J Immunol Methods 2008 337 78-80
20. Schmidt-Supprian M, Murphy C, While B et al,. Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes. Eur Cytokine Netw 2000 11 407-413 (Pubitemid 32268899)
21. van der Plas MJ, van Dissel JT, Nibbering PH. Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type. PLoS One 2009 4 e8071
22. Calandra T, Bernhagen J, Mitchell RA et al,. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994 179 1895-1902 (Pubitemid 24155670)
23. Hsiao HB, Wu JB, Lin H et al,. Kinsenoside Isolated from Anoectochilus Formosanus Suppresses Lipopolysaccharide-Stimulated Inflammatory Reactions in Macrophages and Endotoxin Shock in Mice. Shock July 16, epub ahead of print
24. Calandra T. Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand J Infect Dis 2003 35 573-576 (Pubitemid 37336875)
25. Flegel WA, Baumstark MW, Weinstock C et al,. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 1993 61 5140-5146 (Pubitemid 23353891)
26. Northoff H, Flegel WA, Yurttas R et al,. The role of lipoproteins in the inactivation of endotoxin by serum. Infusionsther Transfusionsmed 1992a 19 202-203
27. Weinstock C, Ullrich H, Hohe R et al,. Low density lipoproteins inhibit endotoxin activation of monocytes. Arterioscler Thromb 1992 12 341-347
28. Northoff H, Flegel WA, Yurttas R et al,. The role of lipoproteins in inactivation of endotoxin by serum. Beitr Infusionsther 1992b 30 195-197
29. Flegel WA, Wolpl A, Mannel DN et al,. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun 1989 57 2237-2245 (Pubitemid 19186908)
30. Toso C, Emamaullee JA, Merani S et al,. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes. Diabetologia 2008 51 1937-1946
31. Akesson L, Gelling RW, Jensen R et al,. Increased lipid oxidation heralds diabetes onset in DR. lyp/lyp rats. Exp Clin Endocrinol Diabetes 2008 116 475-480